semaglutide alzheimer phase 3 Oral fails to slow early Alzheimer's decline in two trials GLP-1 Semaglutide Fails to Outperform

(NewsNation) Millions of women are using GLP-1 drugs like Ozempic and Wegovy to lose weight during menopause, but a bone health expert says the combination could set women up for fractures down the road

GLOBAL GLUTATHIONE MARKET SIZE, BY HEALTH DRINKS, BY GROUP, 2018-2032 (USD MILLION) TABLE 50

If you get the dose wrong, it can cause problems

The optimal Phase III strategy is to demonstrate non-inferiority to tirzepatide at 72 weeks, then pursue superiority via a CVOT and/or MASH indication to unlock premium formulary access

The two medications belong to entirely different drug classes, work through completely separate mechanisms, and produce different clinical outcomes